B2Gold Corp. (BTO) EPS Estimated At $0.03; BIO-AMD (BIAD) SI Increased By 2.82%

February 12, 2018 - By Stephen Andrade

Analysts expect B2Gold Corp. (TSE:BTO) to report $0.03 EPS on March, 15.T_BTO’s profit would be $29.40 million giving it 30.25 P/E if the $0.03 EPS is correct. After having $0.01 EPS previously, B2Gold Corp.’s analysts see 200.00% EPS growth. The stock increased 4.91% or $0.17 during the last trading session, reaching $3.63. About 1.56M shares traded. B2Gold Corp. (TSE:BTO) has 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.

BIO-AMD INCORPORATED (OTCMKTS:BIAD) had an increase of 2.82% in short interest. BIAD’s SI was 14,600 shares in February as released by FINRA. Its up 2.82% from 14,200 shares previously. With 158,800 avg volume, 0 days are for BIO-AMD INCORPORATED (OTCMKTS:BIAD)’s short sellers to cover BIAD’s short positions. It closed at $0.029 lastly. It is down 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.

Bio-AMD, Inc., through its subsidiary, Bio AMD Holdings Limited, focuses on developing hand held electronic medical diagnostic devices. The company has market cap of $1.33 million. It offers point of care medical diagnostic products, including a disposable micro-fluidic test strip to measure prothrombin time/international normalized ratio through a POC blood coagulation monitoring device that enables patient based, anticoagulant drug therapy monitoring; and a digital strip reader to read various lateral flow based immunoassay diagnostic test strips in the areas of cardiac markers, infectious diseases, drugs of abuse, and female wellbeing. It currently has negative earnings. The firm also provides disposable test strip combining micro-fluidics and ‘lab-on-chip’ technology, which offers quantitative measurement into a immunoassay POC platform that detects nanoparticles through magnetic manipulation.

Among 8 analysts covering B2gold Corp. (TSE:BTO), 8 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. B2gold Corp. had 30 analyst reports since August 18, 2015 according to SRatingsIntel. As per Friday, October 21, the company rating was maintained by Scotia Capital. The firm earned “Outperform” rating on Tuesday, December 5 by BMO Capital Markets. The firm has “Outperform” rating by RBC Capital Markets given on Monday, August 24. BMO Capital Markets maintained B2Gold Corp. (TSE:BTO) on Monday, April 3 with “” rating. On Friday, June 16 the stock rating was maintained by BMO Capital Markets with “Outperform”. The stock has “Outperform” rating by Scotia Capital on Friday, November 4. Scotia Capital maintained the shares of BTO in report on Friday, October 14 with “Outperform” rating. TD Securities maintained the shares of BTO in report on Friday, November 4 with “Buy” rating. As per Thursday, February 4, the company rating was initiated by JP Morgan. The firm has “Outperform” rating given on Friday, November 10 by Scotia Capital.

B2Gold Corp., together with its subsidiaries, engages in the exploration and development of mineral properties in Nicaragua, the Philippines, Namibia, Mali, Colombia, Burkina Faso, and Finland. The company has market cap of $3.56 billion. It primarily explores for gold, silver, and copper deposits. It has a 106.76 P/E ratio. The company's production properties include the La Libertad mine with an exploitation concession covering an area of 10,950 hectares and the El Limon mine covering an area of 12,000 hectares located in Nicaragua; the Masbate mine covering an area of approximately 15,209 hectares located in the Philippines; and the Otjikoto mine covering an area of 6,933.99 hectares located in Namibia.